Expedition Therapeutics is gearing up for a phase 2 trek with a $165 million series A that closed Oct. 9. The new funding ...

Receiving dupilumab for 52 weeks lowered the risk for severe exacerbations vs. placebo in adults with COPD and type 2 ...

Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...

The U.S. Food and Drug Administration has approved Jazz Pharmaceuticals and Roche's combination therapy as a maintenance ...

"These emissions drive global warming, exacerbating the very respiratory conditions inhalers are meant to relieve," ...

AMSTERDAM, Sept. 29, 2025 /PRNewswire/ -- Kaia Health, a global leader in digital therapeutics for chronic disease management, today announced a new collaboration with MedImprove, a leading private ...

For a long time, physicians and scientists believed our lungs were sterile (germ-free). But modern science indicates otherwise. Now we know they contain allergens, bacteria or viruses we inhale, such ...

Novel anti-ST2 monoclonal antibody astegolimab modestly reduced chronic obstructive pulmonary disease (COPD) exacerbations in the phase IIb ALIENTO trial. The biologic dosed every 2 weeks reduced ...

Researchers conducted a prospective randomized controlled trial in 74 patients with stage III-IV COPD and prior hospitalization to assess the safety and efficacy of using telemedicine for follow-up.

SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...